Results 1 to 10 of about 71,546 (353)

Echocardiography in left ventricular assist device

Heart Views, 2010
LVAD = Left Ventricular Assist Device; LV = Left Ventricle; LA = Left Atrium; AO = Aorta.
Sherif M Helmy, Alia Albinali, Rachel Hajar   +2 more
doaj   +4 more sources

Use of Right Ventricular Assist Device Post-Left Ventricular Assist Device Placement [PDF]

Hearts
Right heart failure (RHF) is a common manifestation after left ventricular assist device (LVAD) placement and is associated with a high mortality rate. Historically, RV failure requiring an RVAD at the time of LVAD implantation has been associated with ...
Shannon Parness, Tori E. Hester, Harish Pandyaram, Panagiotis Tasoudis, Aurelie E. Merlo   +4 more
doaj   +2 more sources

Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims The continuous flow left ventricular assist device (cf-LVAD) has improved the survival of chronic end-stage heart failure (HF) patients.
Yoonjee Park, Darae Kim, Jeong Hoon Yang, Yang Hyun Cho, Jin-Oh Choi, Eun-Seok Jeon   +5 more
doaj   +1 more source

Percutaneous left ventricular assist devices in refractory cardiac arrest: The role of chest compressions

Resuscitation Plus, 2023
Background: Recent studies describe an emerging role for percutaneous left ventricular assist devices such as Impella CP® as rescue therapy for refractory cardiac arrest.
Adam L. Gottula, Brendan M. McCracken, Takahiro Nakashima, Nicholas L. Greer, Traci A. Cramer, Nadia R. Sutton, Kevin R. Ward, Robert W. Neumar, Mohamad Hakam Tiba, Cindy H. Hsu   +9 more
doaj   +1 more source

Right and left ventricular assist devices are an option for bridge to heart transplantCentral MessagePerspective

JTCVS Open, 2022
Background: Patients with a left ventricular assist device with right ventricular failure are prioritized on the heart transplant waitlist; however, their post-transplant survival is less well characterized.
Yaron D. Barac, MD, PhD, Ronen Toledano, MD, Oliver K. Jawitz, MD, Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Chetan B. Patel, MD, Dan Aravot, MD, Carmelo A. Milano, MD   +7 more
doaj   +1 more source

Surgical outcomes of bridge-to-bridge therapy with extracorporeal left ventricular assist device for acute myocardial infarction in cardiogenic shock

BMC Cardiovascular Disorders, 2022
Background Extracorporeal left ventricular assist device is often required for acute myocardial infarction patients in cardiogenic shock when temporary mechanical circulatory support fails to provide hemodynamic stabilization.
Chiho Tokunaga, Atsushi Iguchi, Hiroyuki Nakajima, Fumiya Chubachi, Yuto Hori, Akitoshi Takazawa, Jun Hayashi, Toshihisa Asakura, Akihiro Yoshitake   +8 more
doaj   +1 more source

Left ventricular assist devices [PDF]

Journal of the Intensive Care Society, 2020
Background There is a growing population of patients in the UK with advanced heart failure who are receiving a left ventricular assist device (LVAD) as a bridge to transplant. This is due to the plateauing number of heart transplantations and the increasing evidence of the effectiveness of these devices.
openaire   +2 more sources

Left ventricular assist devices: a kidney’s perspective [PDF]

Heart Failure Reviews, 2015
The left ventricular assist device (LVAD) has become an established treatment option for patients with refractory heart failure. Many of these patients experience chronic kidney disease (CKD) due to chronic cardiorenal syndrome type II, which is often alleviated quickly following LVAD implantation.
Tromp, T R, de Jonge, N, Joles, J A
openaire   +3 more sources

Ventricular Arrhythmias After Left Ventricular Assist Device [PDF]

Circulation: Arrhythmia and Electrophysiology, 2013
Despite advances in medical therapy, heart failure remains one of the major causes of hospitalizations and deaths in the United States. Approximately 5.7 million patients have heart failure, and it is the direct cause of death for 57 000 individuals annually.1 Although the combination of optimal medical therapy, implantable cardioverter-defibrillators (
Shashima, Nakahara, Christopher, Chien, Jill, Gelow, Khidir, Dalouk, Charles A, Henrikson, James, Mudd, Eric C, Stecker   +6 more
openaire   +2 more sources

Left Ventricular Assist Devices [PDF]

Circulation, 2018
Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage heart failure patients with >22 000 implantations to date. Though originally conceived for bridge-to-transplant indication, significant advancements in medical management as well as technology with arrivals of newer generation devices have improved patient ...
Jason J. Han, Michael A. Acker, Pavan Atluri   +2 more
openaire   +1 more source